Age, certain medications, stomach conditions, and plant-based diets can all interfere with absorption
Compounded GLP-1 medications operate under FDA section 503A oversight and state pharmacy regulation
Nalkiran I, Turan S, Arikan S, Kahraman OT, Acar L, Yaylim I, Ergen A
A sustained increase in resting heart rate of 15 or more beats per minute can indicate excessive GLP-1 receptor stimulation
Addressing these structural and economic barriers is essential to maximizing the real-world impact of incretin-based therapies and ensuring that therapeutic advances translate into improved outcomes across diverse patient populations
See if GLP-1s are a possible option for you